Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on April 25, 2025
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
GlobeNewswire
·
April 25, 2025
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …
Greenheart Gold Announces Filing of Annual Financial Statements and Provides a Corporate Update
GlobeNewswire
·
April 25, 2025
LONGUEUIL, Québec, April 25, 2025 (GLOBE NEWSWIRE) -- Greenheart Gold Inc. (TSXV: GHRT; OTCQB: GHRTF) (the “Company” or “Greenheart Gold”) is pleased to announce that it has filed its annual financial statements and management discussion and analysis for …
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
GlobeNewswire
·
April 25, 2025
Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment benefits in individuals with Duchenne muscular dystrophy (DMD) If approved by the European Commission, …
Evolving Systems Advances Telecommunications Sustainability through Dynamic SIM Allocation (DSA)
EIN Presswire
·
April 25, 2025
DSA helps telecom operators reduce carbon and e-waste by modernizing SIM provisioning with real-time activation and universal SIM SKUs. MANCHESTER, UNITED KINGDOM, April 25, 2025 /EINPresswire.com/ -- Evolving Systems has announced the implementation of …
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
GlobeNewswire
·
April 25, 2025
Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the Clinical …
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
GlobeNewswire
·
April 25, 2025
In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), into a registrational study Company remains confident in continuing to pursue evorpacept in …
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025
GlobeNewswire
·
April 25, 2025
Hamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that …
Paddle Finance Announce launch on Berachain: Liquidity Tools for Assets Most Protocols Ignore
GlobeNewswire
·
April 25, 2025
Tortola, British Virgin Islands, April 25, 2025 (GLOBE NEWSWIRE) -- Paddle Finance has announced its launch on Berachain, bringing liquidity tools for assets that most protocols ignore in the Decentralized Finance industry. While most DeFi protocols chase …
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
GlobeNewswire
·
April 25, 2025
WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …
Oxbridge / SurancePlus to Attend TOKEN2049 Dubai
GlobeNewswire
·
April 25, 2025
GRAND CAYMAN, Cayman Islands, April 25, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized …
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
GlobeNewswire
·
April 25, 2025
BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …
Southpac Trust Nevis Celebrates 25 Years of Excellence as Nevis LLC Registrations Surge
GlobeNewswire
·
April 25, 2025
Photo Courtesy of Southpac Trust CHARLESTOWN, St. Kitts and Nevis, April 25, 2025 (GLOBE NEWSWIRE) -- Southpac Trust Nevis Limited, a leading provider of offshore financial services, announces the celebration of its 25th anniversary, marking a quarter- …
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Calibre Mining Securityholders Vote FOR the Proposed Arrangement with Equinox Gold
GlobeNewswire
·
April 25, 2025
Your vote is important, regardless of the number of Calibre shares you hold. Securityholders are encouraged to vote in advance of the deadline on Tuesday, 29 April at 10:00 a.m. (Vancouver time). For assistance in voting, please contact Laurel Hill …
World of Dypians Wins $450K in BNB Chain’s Support Program and Announces Monumental New Features
GlobeNewswire
·
April 25, 2025
Road Town, Tortola, BVI, April 25, 2025 (GLOBE NEWSWIRE) -- World of Dypians (WoD), a highly immersive MMORPG available on Epic Games, has announced a series of exciting developments that take the game to monumental new heights. Among them are $450,000 in …
Banco Itaú Chile Files Material Event Notice announcing 2025 Ordinary Shareholders’ Meeting Agreements
GlobeNewswire
·
April 25, 2025
SANTIAGO, Chile, April 24, 2025 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (SSE: ITAUCL) (the “Bank”) announced that it filed a Material Event Notice with the Chilean Commission for the Financial Market reporting the agreements taken at the Bank’s Ordinary …
Resolutions Adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meeting for Grupo Aeroportuario del Pacifico on April 24, 2025
GlobeNewswire
·
April 25, 2025
GUADALAJARA, Mexico, April 24, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces the following resolutions adopted at the Annual General Ordinary Shareholders’ Meetings today …